ANI Pharmaceuticals reported $59.6M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 4.34B 56M Jun/2025
ANI Pharmaceuticals USD 59.6M 5.52M Sep/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Novartis USD 5.84B 235M Sep/2025
Perrigo USD 258.8M 37.3M Sep/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025